SHIM
WST icon

Stone House Investment Management’s West Pharmaceutical WST Stock Holding History

Stone House Investment Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.76K Buy
11
+8
+267% +$1.99K ﹤0.01% 545
2025
Q4 		$825 Hold
3
– – ﹤0.01% 660
2025
Q3 		$787 Buy
+3
New +$729 ﹤0.01% 587

Other funds holding WST

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Stone House Investment Management's WST Position: Q1 2026 in Review

Stone House Investment Management increased its West Pharmaceutical (WST) stake by 267% in Q1 2026, buying an estimated $1.99K and bringing the position to 11 shares worth $2.76K. The position accounts for ﹤0.01% of the portfolio, ranked #545.

Stone House Investment Management first reported a position in WST in Q3 2025 and has held it in 3 quarters since. 754 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Stone House Investment Management held 11 shares of West Pharmaceutical worth $2.76K as of Q1 2026.
  • Stone House Investment Management bought 8 West Pharmaceutical shares in Q1 2026, an estimated $1.99K.
  • West Pharmaceutical made up ﹤0.01% of Stone House Investment Management's portfolio in Q1 2026, its #545 holding.
  • Stone House Investment Management first reported a position in West Pharmaceutical in Q3 2025 and has held it in 3 quarters since.
  • 754 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Stone House Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.